CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers

BACKGROUND: Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson’s disease (PD). In this study, we aim to identify CSF candidate risk biomarkers of PD in individuals with LRRK2 mutation carriers....

Descripción completa

Detalles Bibliográficos
Autores principales: Majbour, Nour K., Aasly, Jan O., Hustad, Eldbjørg, Thomas, Mercy A., Vaikath, Nishant N., Elkum, Naser, van de Berg, Wilma D. J., Tokuda, Takahiko, Mollenhauer, Brit, Berendse, Henk W., El-Agnaf, Omar M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201744/
https://www.ncbi.nlm.nih.gov/pubmed/32375873
http://dx.doi.org/10.1186/s40035-020-00192-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201744/
https://www.ncbi.nlm.nih.gov/pubmed/32375873
http://dx.doi.org/10.1186/s40035-020-00192-4

Ejemplares similares